Table 1

Descriptive data of 232 children treated for ROP during 2007–2014 and registered in the Swedish national quality register for ROP

SexN (%)
Girl92 (39.48)
Boy140 (60.32)
Age at examination (year)Mean (SD)6.57
Median6.5
Range2.8–12.3
GA at birth (week)Mean (SD)24.97 (1.63)
Median24.71
Range22.0–30.14
BW (gram)Mean (SD)699 (175)
Median668
Range400–1230
BWSDSMean (SD)−0.34 (0.85)
Median−0.25
Range-2.6-1.4
BPDN (%)
Yes159 (68.53)
No73 (31.47)
NECN (%)
Yes44 (18.97)
No188 (81.03)
Brain lesionN (%)
Yes32 (13.79)
No200 (86.21)
Maximum no of treatmentsMean (SD)1.44 (0.74)
Median1
Range1-5
PNA at first treatmentMean (SD)12.87 (2.90)
Median12.43
Range7.0–25.57
PMA at first treatmentMean (SD)37.85 (3.13)
Median37.14
Range32.43–52.14
  • Brain lesion defined as intraventricular hemorrhage ≥3 and/or periventricular leukomalacia.

  • BPD, bronchopulmonary disease; BW, birth wt; BWSDS, birth weight SD score; GA, gestational age; NEC, necrotising enterocolitis; n, number; PMA, postmenstrual age; PNA, postnatal age; ROP, retinopathy of prematurity.